NeuPath Health Inc.

Equities

NPTH

CA64133P1009

Healthcare Facilities & Services

Delayed Toronto S.E. Other stock markets 10:52:24 16/05/2024 pm IST			5-day change	1st Jan Change
0.17 ^CAD	0.00%		0.00%	-8.11%

15/03	NeuPath Health Narrows Q4 Loss, Revenue Rises	MT
15/03	NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

NeuPath Health Inc. announced that it has received CAD 1.453 million in funding

May 02, 2023

On May 2, 2023, NeuPath Health Inc. closed the transaction. The company has issued 1,453 units for gross proceeds of CAD 1,453,000 in the transaction. The debentures will mature on May 2, 2025 and bear interest at a rate of 10% per annum payable quarterly in arrears in cash.

Latest news about NeuPath Health Inc.

NeuPath Health Narrows Q4 Loss, Revenue Rises	15/03	MT
NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03	CI
NeuPath Health Inc. acquired Assets of The London Spine Centre from The London Spine Centre.	15/01	CI
NeuPath Health Reports Q3 2023 Revenue of $16.1 Million, up 6%	16/11	MT
NeuPath Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11	CI
NeuPath Health Inc. Announces Successful Closing of Updated Credit Facility	13/11	CI
NeuPath Health Closes Sale of Corporate-Owned Medical Facility	05/23/05	MT
An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc..	05/23/05	CI
NeuPath Health Swings to Profit in Q2, Revenue Grows	17/23/17	MT
NeuPath Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17	CI
NeuPath Health Inc. Brief: Record Q2 Total Revenue of $17.1 million	17/23/17	MT
NeuPath Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
NeuPath Health Closes Brokered Private Placement	02/23/02	MT
NeuPath Health Inc. announced that it has received CAD 1.453 million in funding	02/23/02	CI
NeuPath Health Inc. announced that it expects to receive CAD 1.4 million in funding	11/23/11	CI
NeuPath Health Inc. Brief: Edging Lower Although Says Delivered Record Quarterly Revenues and Opened New Fluoroscopy Suite to Patients	30/23/30	MT
NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
NeuPath Health Inc. Auditor Raises 'Going Concern' Doubt	30/23/30	CI
NeuPath Health Agrees to Sell Corporate-owned Medical Facility	15/23/15	MT
An unknown buyer agreed to acquire London medical facility, Ontario from NeuPath Health Inc..	15/23/15	CI
NeuPath Health Q3 Loss $1.14 Million Vs Loss $0.66 Million Year Ago; Revenue Flat at $15.2 Million	17/22/17	MT
NeuPath Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	17/22/17	CI
NeuPath Health Inc Announces Board Changes	19/22/19	CI
NeuPath Health Executive Chair Dianne Carmichael Steps Down, Names Interim CEO; Suspends Software Development	30/22/30	MT
NeuPath Health Inc. Announces Resignation of Dianne Carmichael as Director and Executive Chair	30/22/30	CI

Chart NeuPath Health Inc.

Duration

Period

More charts

Company Profile

NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The Company's health care providers cover a range of specialties, which include physiatrists, neurologists, anesthesiologists, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and nurses.

Sector

Healthcare Facilities & Services

Calendar

23/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.17 CAD

Average target price

0.5 CAD

Spread / Average Target

+194.12%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
NEUPATH HEALTH INC.	-8.11%	70.35L
HCA HEALTHCARE, INC.	+19.55%	8.56TCr
CVS HEALTH CORPORATION	-27.08%	7.06TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	2.7TCr
LABORATORY CORPORATION OF AMERICA HOLDINGS	-5.71%	1.8TCr
FRESENIUS SE & CO. KGAA	+1.60%	1.76TCr
QUEST DIAGNOSTICS INCORPORATED	+3.41%	1.56TCr
REDE D'OR SÃO LUIZ S.A.	+7.79%	1.35TCr
FRESENIUS MEDICAL CARE AG	+9.91%	1.34TCr
NATERA, INC.	+72.99%	1.32TCr

Other Healthcare Facilities & Services